Format

Send to

Choose Destination
Int J Chron Obstruct Pulmon Dis. 2018 May 10;13:1507-1514. doi: 10.2147/COPD.S146390. eCollection 2018.

Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis.

Author information

1
Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece.
2
Doctor Evidence, Client Solutions, Santa Monica, CA, USA.
3
Global Medical Affairs, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
4
Department of Epidemiology and Biostatistics, Imperial College London, London, UK.

Abstract

Rationale:

COPD has been perceived as being a disease of older men. However, >7 million women are estimated to live with COPD in the USA alone. Despite a growing body of literature suggesting an increasing burden of COPD in women, the evidence is limited.

Objectives:

To assess and synthesize the available evidence among population-based epidemiologic studies and calculate the global prevalence of COPD in men and women.

Materials and methods:

A systematic review and meta-analysis reporting gender-specific prevalence of COPD was undertaken. Gender-specific prevalence estimates were abstracted from relevant studies. Associated patient characteristics as well as custom variables pertaining to the diagnostic method and other important epidemiologic covariates were also collected. A Bayesian random-effects meta-analysis was performed investigating gender-specific prevalence of COPD stratified by age, geography, calendar time, study setting, diagnostic method, and disease severity.

Measurements and main results:

Among 194 eligible studies, summary prevalence was 9.23% (95% credible interval [CrI]: 8.16%-10.36%) in men and 6.16% (95% CrI: 5.41%-6.95%) in women. Gender prevalences varied widely by the World Health Organization Global Burden of Disease subregions, with the highest female prevalence found in North America (8.07% vs 7.30%) and in participants in urban settings (13.03% vs 8.34%). Meta-regression indicated that age ≥40 and bronchodilator testing contributed most significantly to heterogeneity of prevalence estimates across studies.

Conclusion:

We conducted the largest ever systematic review and meta-analysis of global prevalence of COPD and the first large gender-specific review. These results will increase awareness of COPD as a critical woman's health issue.

KEYWORDS:

COPD; age; gender; meta-analysis; prevalence; systematic review

PMID:
29785100
PMCID:
PMC5953270
DOI:
10.2147/COPD.S146390
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center